Bone marrow evaluation in patients with leukemia and myelodysplasia

Bone marrow evaluation in patients with leukemia and myelodysplasia - Bone marrow evaluation in AML/MDS

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON38969

Enrollment

120

Registered

2014-02-06

Start date

2014-06-01

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute myeloid leukemia

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: AML/MDS patients undergoing a diagnostic bone marrow-biopsy

Exclusion criteria

Exclusion criteria: Age

Design outcomes

Primary

Measure	Time frame
- Cellular proliferation and differentiation - Gene profiling studies - Molecular markers	—

Countries

Netherlands

Outcome results